Walter A. Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Walter A. Tan has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Mark C. Bates
West Virginia University Department of Surgery, West Virginia University School of Medicine
1 shared publication Mark H. Wholey
From the Departments of Radiology and Cardiology, Pittsburgh Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
1 shared publication
Latest Publications
- Open Access
- 1 August 2001
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 14 (4) , 465-474
Cerebral Protection Systems for Distal Emboli During Carotid Artery Interventions
Carotid angioplasty and stenting is associated with liberation of cerebral emboli that can cause periprocedural stroke. There are currently three classes of emboli protection devices (EPDs) that are undergoing feasibility studies and one randomized clinical trial. Preliminary data from a small series appear to be promising, and there appears to be attenuation of embolic signals on a cerebral Doppler exam with EPD use. However, rare strokes and patient intolerance due to imposed ischemia have been observed. The advantages and disadvantages of each EPD class and the issues involving clinical trials and surrogate end points in this area of study are discussed.
- 1 August 2001
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 14 (4) , 465-474
Open AccessCerebral Protection Systems for Distal Emboli During Carotid Artery Interventions
Carotid angioplasty and stenting is associated with liberation of cerebral emboli that can cause periprocedural stroke. There are currently three classes of emboli protection devices (EPDs) that are undergoing feasibility studies and one randomized clinical trial. Preliminary data from a small series appear to be promising, and there appears to be attenuation of embolic signals on a cerebral Doppler exam with EPD use. However, rare strokes and patient intolerance due to imposed ischemia have been observed. The advantages and disadvantages of each EPD class and the issues involving clinical trials and surrogate end points in this area of study are discussed.